Mark Barnett Johnson, MD | |
2020 Palomino Ln Ste 100, Las Vegas, NV 89106-4894 | |
(702) 759-8600 | |
Not Available |
Full Name | Mark Barnett Johnson |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 11 Years |
Location | 2020 Palomino Ln Ste 100, Las Vegas, Nevada |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740623818 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0204X | Radiology - Vascular & Interventional Radiology | 18967 (Nevada) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kalispell Regional Medical Center | Kalispell, MT | Hospital |
North Valley Hospital | Whitefish, MT | Hospital |
Cabinet Peaks Medical Center | Libby, MT | Hospital |
Clark Fork Valley Hospital | Plains, MT | Hospital |
Pondera Medical Center | Conrad, MT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kalispell Regional Medical Center Inc | 5294644381 | 354 |
St Lukes Community Hospital | 5496659567 | 58 |
Northwest Imaging, Pc | 8426969155 | 20 |
News Archive
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
The Tej Kohli Cornea Institute [TKCI] in partnership with world-renowned LV Prasad Eye Institute (LVPEI) is proud to announce the launch of the TKCI Srujana Innovation Award. The award encourages ideas that will lead to the next big breakthrough in treatment of corneal blindness. It launches in conjunction with the fourth annual ‘Engineering The Eye Workshop' at which LVPEI clinicians and MIT engineers meet every July in Hyderabad, India.
Pursuing our own short term interests by cheating on the rest of the population is not the preserve of the human race.
Cephalon, Inc. today announced that the primary endpoint was not met in a Phase II clinical trial that examined NUVIGIL (armodafinil) Tablets [C-IV] as an adjunctive therapy for the treatment of the negative symptoms of schizophrenia, which include problems with motivation and emotional withdrawal.
› Verified 4 days ago
Entity Name | St Lukes Community Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306911169 PECOS PAC ID: 5496659567 Enrollment ID: O20031121000276 |
News Archive
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
The Tej Kohli Cornea Institute [TKCI] in partnership with world-renowned LV Prasad Eye Institute (LVPEI) is proud to announce the launch of the TKCI Srujana Innovation Award. The award encourages ideas that will lead to the next big breakthrough in treatment of corneal blindness. It launches in conjunction with the fourth annual ‘Engineering The Eye Workshop' at which LVPEI clinicians and MIT engineers meet every July in Hyderabad, India.
Pursuing our own short term interests by cheating on the rest of the population is not the preserve of the human race.
Cephalon, Inc. today announced that the primary endpoint was not met in a Phase II clinical trial that examined NUVIGIL (armodafinil) Tablets [C-IV] as an adjunctive therapy for the treatment of the negative symptoms of schizophrenia, which include problems with motivation and emotional withdrawal.
› Verified 4 days ago
Entity Name | Kalispell Regional Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235333139 PECOS PAC ID: 5294644381 Enrollment ID: O20031122000142 |
News Archive
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
The Tej Kohli Cornea Institute [TKCI] in partnership with world-renowned LV Prasad Eye Institute (LVPEI) is proud to announce the launch of the TKCI Srujana Innovation Award. The award encourages ideas that will lead to the next big breakthrough in treatment of corneal blindness. It launches in conjunction with the fourth annual ‘Engineering The Eye Workshop' at which LVPEI clinicians and MIT engineers meet every July in Hyderabad, India.
Pursuing our own short term interests by cheating on the rest of the population is not the preserve of the human race.
Cephalon, Inc. today announced that the primary endpoint was not met in a Phase II clinical trial that examined NUVIGIL (armodafinil) Tablets [C-IV] as an adjunctive therapy for the treatment of the negative symptoms of schizophrenia, which include problems with motivation and emotional withdrawal.
› Verified 4 days ago
Entity Name | Northwest Imaging, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386713832 PECOS PAC ID: 8426969155 Enrollment ID: O20040309000627 |
News Archive
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
The Tej Kohli Cornea Institute [TKCI] in partnership with world-renowned LV Prasad Eye Institute (LVPEI) is proud to announce the launch of the TKCI Srujana Innovation Award. The award encourages ideas that will lead to the next big breakthrough in treatment of corneal blindness. It launches in conjunction with the fourth annual ‘Engineering The Eye Workshop' at which LVPEI clinicians and MIT engineers meet every July in Hyderabad, India.
Pursuing our own short term interests by cheating on the rest of the population is not the preserve of the human race.
Cephalon, Inc. today announced that the primary endpoint was not met in a Phase II clinical trial that examined NUVIGIL (armodafinil) Tablets [C-IV] as an adjunctive therapy for the treatment of the negative symptoms of schizophrenia, which include problems with motivation and emotional withdrawal.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Mark Barnett Johnson, MD 2020 Palomino Ln Ste 100, Las Vegas, NV 89106-4894 Ph: (702) 759-8600 | Mark Barnett Johnson, MD 2020 Palomino Ln Ste 100, Las Vegas, NV 89106-4894 Ph: (702) 759-8600 |
News Archive
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are launching a new research study to find the best way to give blood transfusions for severely injured patients predicted to require massive blood transfusions upon arrival to the Memorial Hermann-Texas Medical Center emergency department. Bryan Cotton, M.D., of UTHealth is principal investigator for this clinical study.
The Tej Kohli Cornea Institute [TKCI] in partnership with world-renowned LV Prasad Eye Institute (LVPEI) is proud to announce the launch of the TKCI Srujana Innovation Award. The award encourages ideas that will lead to the next big breakthrough in treatment of corneal blindness. It launches in conjunction with the fourth annual ‘Engineering The Eye Workshop' at which LVPEI clinicians and MIT engineers meet every July in Hyderabad, India.
Pursuing our own short term interests by cheating on the rest of the population is not the preserve of the human race.
Cephalon, Inc. today announced that the primary endpoint was not met in a Phase II clinical trial that examined NUVIGIL (armodafinil) Tablets [C-IV] as an adjunctive therapy for the treatment of the negative symptoms of schizophrenia, which include problems with motivation and emotional withdrawal.
› Verified 4 days ago
Dr. Douglas Glen Larson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2020 Palomino Ln, #100, Las Vegas, NV 89106 Phone: 702-759-8600 | |
Saravanan Valliappan, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5495 S Rainbow Blvd Ste 101, Las Vegas, NV 89118 Phone: 702-477-0772 | |
Ho Viet Nguyen, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2950 S Maryland Pkwy, Las Vegas, NV 89109 Phone: 702-240-1215 Fax: 702-243-7531 | |
Gorden Chu, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2950 S Maryland Pkwy, Las Vegas, NV 89109 Phone: 702-732-6000 Fax: 702-243-7531 | |
Nader Beheshti, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5495 S Rainbow Blvd Ste 101, Las Vegas, NV 89118 Phone: 702-477-0772 | |
Joshua Rosenberg, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 2020 Palomino Lane, Ste # 100, Las Vegas, NV 89106 Phone: 702-759-8600 Fax: 702-384-1815 | |
Skyler Wayne Greene, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2950 S Maryland Pkwy, Las Vegas, NV 89109 Phone: 702-732-6000 |